National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Adult Hodgkin Lymphoma Treatment (PDQ®)     
Last Modified: 10/01/2009
Health Professional Version
Changes to This Summary (10/01/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Treatment Option Overview 1

Added Alm El-Din et al. as reference 27 2.

Early Unfavorable Hodgkin Lymphoma 3

Added Bar Ad et al. as reference 14 4.

Recurrent Adult Hodgkin Lymphoma 5

Added Morschhauser et al. as reference 31 6.


Table of Links

1http://www.cancer.gov/cancertopics/pdq/treatment/adulthodgkins/HealthProfession
al/36.cdr#Section_36
2http://www.cancer.gov/cancertopics/pdq/treatment/adulthodgkins/HealthProfession
al/239.cdr#Section_239
3http://www.cancer.gov/cancertopics/pdq/treatment/adulthodgkins/HealthProfession
al/373.cdr#Section_373
4http://www.cancer.gov/cancertopics/pdq/treatment/adulthodgkins/HealthProfession
al/423.cdr#Section_423
5http://www.cancer.gov/cancertopics/pdq/treatment/adulthodgkins/HealthProfession
al/174.cdr#Section_174
6http://www.cancer.gov/cancertopics/pdq/treatment/adulthodgkins/HealthProfession
al/178.cdr#Section_178